USRD vs. FMED ETF Comparison
Comparison of Themes US R&D Champions ETF (USRD) to Fidelity Disruptive Medicine ETF (FMED)
USRD
Themes US R&D Champions ETF
USRD Description
The index is designed to provide exposure to U.S. companies in the large- and mid- capitalization segments that rank in the top 50 companies based on the index Provider"s R&D intensity metric. The fund will invest, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities that comprise the index. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$31.69
Average Daily Volume
143
Number of Holdings
*
50
* may have additional holdings in another (foreign) market
FMED
Fidelity Disruptive Medicine ETF
FMED Description
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.Grade (RS Rating)
Last Trade
$25.44
Average Daily Volume
4,762
Number of Holdings
*
52
* may have additional holdings in another (foreign) market
Performance
Period | USRD | FMED |
---|---|---|
30 Days | 2.17% | -1.34% |
60 Days | 2.27% | -2.99% |
90 Days | 3.37% | -1.48% |
12 Months | 18.13% |
USRD Overweight 43 Positions Relative to FMED
Symbol | Grade | Weight | |
---|---|---|---|
FTNT | C | 2.39% | |
TRMB | B | 2.33% | |
EXPE | B | 2.31% | |
GM | B | 2.25% | |
INTU | C | 2.25% | |
CMI | A | 2.19% | |
ORCL | B | 2.19% | |
ZM | B | 2.17% | |
HPE | B | 2.16% | |
NOW | A | 2.15% | |
EA | A | 2.12% | |
CDNS | B | 2.11% | |
ADBE | C | 2.1% | |
ADSK | A | 2.1% | |
CSCO | B | 2.07% | |
ANSS | B | 2.06% | |
SNPS | B | 2.04% | |
NTAP | C | 2.03% | |
ROP | B | 2.02% | |
GOOGL | C | 2.0% | |
KEYS | A | 2.0% | |
IBM | C | 1.98% | |
QCOM | F | 1.97% | |
TTD | B | 1.97% | |
CSGP | D | 1.96% | |
MDT | D | 1.96% | |
META | D | 1.95% | |
NOC | D | 1.94% | |
HOLX | D | 1.94% | |
JNJ | D | 1.93% | |
ANET | C | 1.93% | |
DOX | D | 1.89% | |
AMAT | F | 1.89% | |
LRCX | F | 1.88% | |
GEHC | F | 1.87% | |
AMD | F | 1.87% | |
EL | F | 1.85% | |
MELI | D | 1.84% | |
CTVA | C | 1.81% | |
LDOS | C | 1.75% | |
AKAM | D | 1.73% | |
MPWR | F | 1.5% | |
ENPH | F | 1.43% |
USRD Underweight 45 Positions Relative to FMED
Symbol | Grade | Weight | |
---|---|---|---|
UNH | C | -4.7% | |
PODD | C | -4.44% | |
DHR | F | -3.8% | |
ARGX | A | -3.27% | |
ALNY | D | -2.9% | |
SYK | C | -2.73% | |
EXAS | D | -2.72% | |
PEN | B | -2.64% | |
LFST | C | -2.41% | |
MASI | A | -2.01% | |
LEGN | F | -1.95% | |
INSP | D | -1.92% | |
DXCM | D | -1.88% | |
TMO | F | -1.87% | |
PRCT | B | -1.65% | |
ZLAB | C | -1.54% | |
AGL | F | -1.43% | |
GKOS | B | -1.42% | |
RGEN | D | -1.34% | |
PRVA | B | -1.34% | |
KROS | D | -1.34% | |
JANX | C | -1.32% | |
RMD | C | -1.3% | |
CRNX | C | -1.23% | |
CYTK | F | -1.19% | |
XENE | D | -1.17% | |
DOCS | C | -1.14% | |
DYN | F | -1.13% | |
PCVX | D | -1.13% | |
BRKR | D | -1.12% | |
WST | C | -1.01% | |
TNDM | F | -1.0% | |
PHR | F | -0.99% | |
CNC | D | -0.98% | |
ASND | D | -0.88% | |
VRTX | F | -0.84% | |
TXG | F | -0.63% | |
NTRA | B | -0.56% | |
ACLX | C | -0.45% | |
DNLI | D | -0.45% | |
NRIX | D | -0.44% | |
IRTC | D | -0.44% | |
DAWN | F | -0.41% | |
BNTX | D | -0.4% | |
ANAB | F | -0.24% |
USRD: Top Represented Industries & Keywords
Industries:
Software - Application
Medical Devices
Semiconductor Equipment & Materials
Semiconductors
Communication Equipment
Diversified Industrials
Drug Manufacturers - Major
Information Technology Services
Internet Content & Information
Medical Instruments & Supplies
Scientific & Technical Instruments
Software - Infrastructure
Aerospace & Defense
Agricultural Inputs
Auto Manufacturers
Biotechnology
Computer Systems
Data Storage
Electronic Gaming & Multimedia
Health Information Services
FMED: Top Represented Industries & Keywords